Fasting Insulin Measurement

Clinical Applications

• The American Diabetes Association recommends that fasting insulin measurement be used primarily for research purposes and not as a routine diagnostic test for most individuals with diabetes or at risk of diabetes or cardiovascular disease 1
• Fasting insulin levels can serve as a marker of insulin resistance, particularly in individuals with normal glucose tolerance, although this is more relevant in a research context 1
• The measurement of fasting insulin is essential in the investigation of non-diabetic hypoglycemia to rule out hypoglycemia due to surreptitious administration of insulin 1
• The diagnosis of an insulinoma is based on the persistence of inappropriately elevated insulin concentrations in the face of low glucose levels 1
• Fasting insulin can be used to evaluate components of the metabolic syndrome, particularly in children and adolescents at risk of developing type 2 diabetes 2, 3

Diagnostic Alternatives

• For distinguishing between type 1 and type 2 diabetes, measuring fasting C-peptide when fasting plasma glucose is ≤220 mg/dL may be more useful 1
• For routine diagnosis and follow-up of diabetes, HbA1c and fasting glucose remain the tests of choice 4

Special Considerations

• In children at risk of type 2 diabetes, fasting glucose testing is recommended for those who are overweight, have a family history of type 2 diabetes, belong to high-risk ethnic groups, or show signs of insulin resistance 2
• In pregnant women, fasting glucose concentrations are lower, but postprandial glucose and insulin levels are substantially higher than in non-pregnant women 5

Fasting Insulin Level Interpretation and Management

Clinical Evaluation and Management

• If a patient has symptoms of hypoglycemia despite a normal insulin level, further evaluation for insulinoma may be needed, including a 48-72 hour observed fast if hypoglycemia is suspected, as recommended by the National Comprehensive Cancer Network 6, 7
• A healthy diet is recommended for maintaining metabolic health, as suggested by guidelines from the National Comprehensive Cancer Network 6

Diagnostic Considerations

• For suspected insulinoma, additional testing would include a 48-72 hour observed fast if hypoglycemia is suspected, as recommended by the National Comprehensive Cancer Network 6, 7

Pre‑Test Preparation and Sample Collection for Fasting Insulin Measurement

Fasting Requirements

• An overnight fast of at least 8 hours without any caloric intake is required before drawing a fasting insulin sample. 8
• Patients should follow an unrestricted diet containing ≥150 g of carbohydrate per day for a minimum of 3 days preceding the test to stabilize insulin secretion. 9
• Physical activity should remain unrestricted (no imposed limitation) in the days leading up to the fasting insulin measurement. 9

Timing and Patient Conditions

• The blood draw must be performed in the morning after the overnight fast to minimize diurnal variation in insulin levels. 9
• During any concurrent glucose tolerance testing, the patient should remain seated and avoid smoking to prevent acute alterations in insulin and glucose concentrations. 9

Sample Collection Procedure

• A venous blood sample should be collected after confirming the required fasting period to ensure accurate insulin measurement. 9

Guidelines for the Clinical Use of Insulin Measurements

Evaluation of Suspected Insulinoma

• In patients undergoing assessment for endogenous hyperinsulinemic hypoglycemia, insulin, C‑peptide, proinsulin, and glucose should be measured simultaneously during a documented hypoglycemic episode to accurately diagnose insulinoma. [10][11]

Insulin Therapy Decision‑Making in Hospitalized Type 2 Diabetes

• For hospitalized individuals with type 2 diabetes, decisions regarding insulin therapy are guided by target glucose levels and overall clinical status, rather than by measuring endogenous insulin concentrations. [12][13]